Rossing P, Bakris G, Perkovic V, Pratley R, et al. Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor
Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A
FLOW Trial Prespecified Secondary Analysis. Diabetes Care 2025 Jul 29:dc250472. doi: 10.2337/dc25-0472.
PMID: 40730031
|